Vancouver, British Columbia (FSCwire) - LED Medical Diagnostics Inc. ("LED Medical" or "the Company"), has announced that its wholly-owned subsidiary, Apteryx, Inc., has signed a SaaS (Software-as-a-Service) agreement with a large, North American provider of dental software (“the Customer”) that will allow for dental practices to use XVWeb® cloud imaging with the Customer’s cloud practice management system.

 

The Customer will include XVWeb in their cloud practice management system’s base package. The management system communicates directly and seamlessly with XVWeb for clinical image management, processing and analysis, while providing access to clinical images from any web-connected device. XVWeb is imaging device agnostic, giving customers the choice of utilizing most imaging acquisition devices from major manufacturers.

 

“Agreements like this allow for greater market penetration and awareness for our XVWeb product,” stated Lamar Roberts, president of LED and Apteryx. “This is an important step in our vision of leading the industry toward the rapid adoption of cloud imaging technologies.”

 

To learn more about XVWeb, visit www.apteryx.com/xvweb.

 

About LED Medical Diagnostics Inc.

 

LED Medical Diagnostics Inc. is a dental imaging technology provider focused on delivering state-of-the-art imaging software and systems. Through its wholly-owned subsidiaries LED Dental Inc., LED Dental Ltd., and Apteryx, Inc., LED Medical has provided dentists and oral health specialists with advanced diagnostic imaging products and software for over 20 years. LED’s proprietary technologies include the VELscope Vx Enhanced Oral Assessment and TUXEDO Intraoral Sensors, in addition to Apteryx’s XrayVision, XVWeb and XrayVision DCV imaging software solutions.

 

Backed by an experienced leadership team and dedicated to a higher level of service and support, LED is committed to providing dental practitioners with the best technology available by identifying and adding leading products to its growing portfolio. The Company is currently listed on the TSX-V under the symbol LMD, the OTCQB under the symbol LEDIF, as well as the Frankfurt Stock Exchange under the symbol LME.

 

Media Contact:

 

LED Dental

Chris Koch

Phone: 678.293.9413

Email: chris.koch@leddental.com

 

Corporate Contact:

 

LED Medical

David Gane, CEO

Phone: 604.434.4614 x227

Email: david.gane@leddental.com

 

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

 

Forward Looking Statements

 

This press release contains statements which, to the extent that they are not recitations of historical fact, may constitute forward-looking information under applicable Canadian securities legislation that involve risks and uncertainties. Such forward-looking statements or information include statements regarding, but not limited to the Company's future growth strategy, its distribution strategy and product offerings, potential expansion of the Company's technology to other medical applications or markets, or the potential introduction of new technologies by the Company. Persons reading this press release are cautioned that such statements or information are only predictions, and that the Corporation's actual future results or performance may be materially different. Factors that could cause actual events or results to differ materially from those suggested by these forward-looking statements include, but are not limited to competition risks, distributor risks, product development risks such as regulatory, design, intellectual property and other factors described in the Corporation's reports filed on SEDAR including its Annual Information Form and financial report for the year ended December 31, 2017.  These and other factors should be considered carefully and readers should not place undue reliance on such forward-looking information. All forward-looking statements made in this press release are qualified by this cautionary statement and there can be no assurance that actual results or developments anticipated by the Company will be realized. The Company disclaims any intention or obligation to update or revise forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

To view the associated document to this release, please click on the following link:
public://news_release_pdf/LED02152018.pdf

To view the original release, please click here

Source: LED Medical Diagnostics Inc. (TSX Venture:LMD, OTCQB:LEDIF, FWB:LME)

To follow LED Medical Diagnostics Inc. on your favorite social media platform or financial websites, please click on the icons below.

 

Maximum News Dissemination by FSCwire. https://www.fscwire.com

Copyright © 2018 FSCwire